STAAR Surgical Debt to Equity Ratio 2010-2024 | STAA
Current and historical debt to equity ratio values for STAAR Surgical (STAA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. STAAR Surgical debt/equity for the three months ending September 30, 2024 was 0.00.
STAAR Surgical Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-09-30 |
$0.11B |
$0.43B |
0.26 |
2024-06-30 |
$0.10B |
$0.41B |
0.25 |
2024-03-31 |
$0.10B |
$0.39B |
0.25 |
2023-12-31 |
$0.10B |
$0.39B |
0.27 |
2023-09-30 |
$0.09B |
$0.38B |
0.25 |
2023-06-30 |
$0.09B |
$0.35B |
0.25 |
2023-03-31 |
$0.08B |
$0.34B |
0.24 |
2022-12-31 |
$0.08B |
$0.34B |
0.25 |
2022-09-30 |
$0.08B |
$0.32B |
0.23 |
2022-06-30 |
$0.08B |
$0.30B |
0.26 |
2022-03-31 |
$0.08B |
$0.28B |
0.27 |
2021-12-31 |
$0.09B |
$0.26B |
0.34 |
2021-09-30 |
$0.08B |
$0.25B |
0.30 |
2021-06-30 |
$0.06B |
$0.24B |
0.26 |
2021-03-31 |
$0.05B |
$0.21B |
0.24 |
2020-12-31 |
$0.06B |
$0.20B |
0.31 |
2020-09-30 |
$0.05B |
$0.19B |
0.26 |
2020-06-30 |
$0.04B |
$0.18B |
0.25 |
2020-03-31 |
$0.04B |
$0.17B |
0.25 |
2019-12-31 |
$0.05B |
$0.16B |
0.30 |
2019-09-30 |
$0.04B |
$0.15B |
0.29 |
2019-06-30 |
$0.04B |
$0.14B |
0.29 |
2019-03-31 |
$0.04B |
$0.14B |
0.29 |
2018-12-31 |
$0.04B |
$0.13B |
0.26 |
2018-09-30 |
$0.03B |
$0.13B |
0.27 |
2018-06-30 |
$0.03B |
$0.05B |
0.62 |
2018-03-31 |
$0.03B |
$0.05B |
0.71 |
2017-12-31 |
$0.03B |
$0.04B |
0.58 |
2017-09-30 |
$0.03B |
$0.04B |
0.79 |
2017-06-30 |
$0.03B |
$0.04B |
0.66 |
2017-03-31 |
$0.03B |
$0.04B |
0.77 |
2016-12-31 |
$0.03B |
$0.04B |
0.73 |
2016-09-30 |
$0.03B |
$0.04B |
0.76 |
2016-06-30 |
$0.03B |
$0.04B |
0.72 |
2016-03-31 |
$0.02B |
$0.04B |
0.61 |
2015-12-31 |
$0.02B |
$0.04B |
0.62 |
2015-09-30 |
$0.02B |
$0.04B |
0.57 |
2015-06-30 |
$0.02B |
$0.04B |
0.52 |
2015-03-31 |
$0.02B |
$0.04B |
0.56 |
2014-12-31 |
$0.02B |
$0.04B |
0.59 |
2014-09-30 |
$0.02B |
$0.04B |
0.55 |
2014-06-30 |
$0.02B |
$0.04B |
0.54 |
2014-03-31 |
$0.02B |
$0.04B |
0.56 |
2013-12-31 |
$0.02B |
$0.04B |
0.59 |
2013-09-30 |
$0.02B |
$0.04B |
0.57 |
2013-06-30 |
$0.02B |
$0.04B |
0.58 |
2013-03-31 |
$0.02B |
$0.03B |
0.61 |
2012-12-31 |
$0.02B |
$0.03B |
0.73 |
2012-09-30 |
$0.02B |
$0.03B |
0.59 |
2012-06-30 |
$0.02B |
$0.03B |
0.58 |
2012-03-31 |
$0.02B |
$0.03B |
0.58 |
2011-12-31 |
$0.02B |
$0.03B |
0.66 |
2011-09-30 |
$0.02B |
$0.03B |
0.62 |
2011-06-30 |
$0.02B |
$0.03B |
0.67 |
2011-03-31 |
$0.02B |
$0.02B |
0.72 |
2010-12-31 |
$0.02B |
$0.02B |
0.81 |
2010-09-30 |
$0.02B |
$0.02B |
0.78 |
2010-06-30 |
$0.02B |
$0.02B |
0.72 |
2010-03-31 |
$0.03B |
$0.02B |
1.41 |
2009-12-31 |
$0.04B |
$0.02B |
1.79 |
2009-09-30 |
$0.04B |
$0.02B |
1.64 |
2009-06-30 |
$0.04B |
$0.02B |
1.55 |
2009-03-31 |
$0.04B |
$0.01B |
2.46 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$1.315B |
$0.322B |
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|